Delivery of plasmid encoding interleukin-12 gene into hepatocytes by conjugated polyethylenimine-based nanoparticles-Reference-Cited by-同舟云学术

Delivery of plasmid encoding interleukin-12 gene into hepatocytes by conjugated polyethylenimine-based nanoparticles

Published:2016-06-30 Issue:5 Volume:45 Page:1036-1044
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Khalvati Bahman¹,Sheikhsaran Fatemeh¹,Sharifzadeh Sedigheh²,Kalantari Tahereh²,Behzad Behbahani Abbas²,Jamshidzadeh Akram³,Dehshahri Ali¹⁴

Affiliation:

1. Department of Pharmaceutical Biotechnology & Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran;

2. Diagnostic Laboratory, Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran;

3. Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran;

4. Research Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran

Funder

Shiraz University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2016.1202256

Reference41 articles.

1. A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study